Podcast: Download (Duration: 1:02 — 1.4MB)
Subscribe: RSS
The amyloid hypothesis. That’s the idea that accumulation of a material called amyloid in the brain leads to Alzheimer’s disease. Acceptance of this idea has led the FDA to approve aducanumab, which reduces amyloid, but isn’t known to improve any …
Podcast: Download (Duration: 1:03 — 1.5MB)
Subscribe: RSS
Aducanumab or Aduhelm is a newly approved medicine for treating Alzheimer’s disease, with many experts asserting that it should never have gotten FDA approval. Caleb Alexander, an internal medicine expert at Johns Hopkins and a member of the FDA review …
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Aduhelm is the proprietary name for aducanumab, a just approved medication for treatment of Alzheimer’s disease. Caleb Alexander, an internal medicine expert at Johns Hopkins, sat on the FDA review board for this medicine and explains why he voted no …
Should a new Alzheimer’s drug have been approved by the FDA? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Have you heard of the ‘nicotine hypothesis’? That’s the idea put forward by supposed scientific studies that somehow nicotine helped protect people from severe Covid-19 disease. Michael Blaha, a cardiologist at Johns Hopkins and tobacco cessation advocate, says there’s no …
Is it possible nicotine has some benefit in Covid-19? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:01 — 1.4MB)
Subscribe: RSS
What helps people be less susceptible to Covid-19 infection and severe illness? Several recently published scientific papers appear to support the so-called ‘nicotine hypothesis,’ suggesting that nicotine may be beneficial. Micheal Blaha, a cardiologist at Johns Hopkins and tobacco cessation …
Can nicotine protect people against Covid-19? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:03 — 1.5MB)
Subscribe: RSS
Magnetic resonance imaging or MRI is sometimes used to examine the prostate gland when cancer is suspected and a biopsy is being considered. Now a new study demonstrates its benefits. William Nelson, director of the Kimmel Cancer Center at Johns …
